Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,798 public trials 1,412 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases trial results

Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

NCT07227415

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, +30 more
Locations
  • Mayo Clinic Building- Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 128 locations
View Trial Details
Recruiting

A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial

NCT05805709

Conditions
Acute Kidney Injury, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Yale University New Haven, Connecticut, United States
  • Cleveland Clinic Weston Hospital Weston, Florida, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Recruiting

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

NCT06527872

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Columbus, Ohio, United States
  • GSK Investigational Site Hixson, Tennessee, United States
View Trial Details
Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

NCT06661720

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 415 locations
View Trial Details

Related conditions